These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6834385)

  • 41. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbachol-induced potentiation and inhibition of acid secretion by guinea pig gastric gland.
    Kajimura M; Haga T; Ichiyama A; Kaneko E; Honda N
    Eur J Pharmacol; 1990 Mar; 178(1):59-69. PubMed ID: 2332028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Muscarinic receptor subtypes in the rat prostate gland.
    Lau WA; Pennefather JN
    Eur J Pharmacol; 1998 Feb; 343(2-3):151-6. PubMed ID: 9570462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of direct competition for, and indirect influences on, striatal muscarinic cholinergic receptors: in vivo [3H]quinuclidinyl benzilate binding in rats.
    Pelham RW; Munsat TL
    Brain Res; 1979 Aug; 171(3):473-80. PubMed ID: 476482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolved pyrrolidine, piperidine, and perhydroazepine analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
    Lundkvist JR; Vargas HM; Caldirola P; Ringdahl B; Hacksell U
    J Med Chem; 1990 Dec; 33(12):3182-9. PubMed ID: 2258904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Labeling of rat heart muscarinic receptors using the new M2 selective antagonist [3H]AF-DX 384.
    Entzeroth M; Mayer N
    Biochem Pharmacol; 1990 Oct; 40(7):1674-6. PubMed ID: 2222523
    [No Abstract]   [Full Text] [Related]  

  • 49. Characterization of muscarinic cholinergic receptors in the crab nervous system.
    Barker DL; Murray TF; Siebenaller JF; Mpitsos GJ
    J Neurochem; 1986 Feb; 46(2):583-8. PubMed ID: 3941321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes-induced alterations in the properties of muscarinic cholinergic receptors in rat vas deferens.
    Kamai T; Fukumoto Y; Gousse A; Yoshida M; Davenport TA; Weiss RM; Latifpour J
    J Urol; 1994 Sep; 152(3):1017-21. PubMed ID: 8051725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of regional variations in the affinities of muscarinic agonists in the rat brain.
    Ellis J; Hoss W
    Brain Res; 1980 Jul; 193(1):189-98. PubMed ID: 7378815
    [No Abstract]   [Full Text] [Related]  

  • 53. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
    Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
    J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscarinic receptors on cultured cells of rat hippocampus: cholinergic regulation and presence of subtypes.
    Rimvall K; Keller F; Waser PG
    Eur J Pharmacol; 1989 Jan; 160(1):1-9. PubMed ID: 2714354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of [3H]quinuclidinyl benzilate binding sites in frontal cortex.
    Ravikumar BV; Sastry PS
    J Neurochem; 1985 Jan; 44(1):240-6. PubMed ID: 3964831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting alpha-2 adrenoceptor agonist activity.
    DiJoseph JF; Eash JR; Mir GN
    J Pharmacol Exp Ther; 1987 Apr; 241(1):97-102. PubMed ID: 2883297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Muscarinic cholinergic receptors in pancreatic acinar carcinoma of rat.
    Taton G; Delhaye M; Swillens S; Morisset J; Larose L; Longnecker DS; Poirier GG
    Int J Cancer; 1985 Apr; 35(4):493-7. PubMed ID: 2580801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives.
    Wadsworth HJ; Jenkins SM; Orlek BS; Cassidy F; Clark MS; Brown F; Riley GJ; Graves D; Hawkins J; Naylor CB
    J Med Chem; 1992 Apr; 35(7):1280-90. PubMed ID: 1560440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.